Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Tunitas Therapeutics
AddedFeb 17, 2024
UpdatedJun 18, 2026
Tunitas Therapeutics

Tunitas Therapeutics

Tunitas Therapeutics: A biopharmaceutical firm innovating allergy immunotherapy treatments.

HQ
Los Altos, CA, US
Founded
2008
Overview
Compare
Fundraising
Employees
Website

Tunitas Therapeutics, founded with a mission to revolutionize allergy treatment, is a biopharmaceutical company focused on developing advanced protein therapeutics for allergy immunotherapy. The company's vision is to provide effective, long-lasting solutions for allergy sufferers through innovative medical treatments. Tunitas Therapeutics aims to address the significant unmet needs in the allergy market by offering novel therapies that improve patient outcomes and quality of life.

Notable figures associated with Tunitas Therapeutics include experienced leaders in biotechnology and pharmaceutical development. The company has garnered attention from key investors in the biopharmaceutical sector, contributing to its growth and research capabilities. Tunitas Therapeutics has achieved significant milestones in preclinical and clinical trials, demonstrating the potential efficacy of its treatments. The company's impact is marked by its commitment to transforming allergy care and its progress toward bringing new therapeutic options to market.

Tunitas Therapeutics - Similar Companies

Alladapt Immunotherapeutics logo

Alladapt Immunotherapeutics

alladapt.com

Tizona Therapeutics logo

Tizona Therapeutics

tizonatx.com

Intrommune Therapeutics logo

Intrommune Therapeutics

intrommune.com

Moonlight Therapeutics logo

Moonlight Therapeutics

moonlighttx.com

Therini Bio logo

Therini Bio

therinibio.com

Tentarix Biotherapeutics logo

Tentarix Biotherapeutics

tentarix.com

Attune Pharmaceuticals logo

Attune Pharmaceuticals

Akttyva Therapeutics logo

Akttyva Therapeutics

akttyva.com

LTZ Therapeutics logo

LTZ Therapeutics

Tigris Pharmaceuticals logo

Tigris Pharmaceuticals

tigrispharma.com

Thesan Pharmaceuticals logo

Thesan Pharmaceuticals

thesanpharma.com

Osprey Pharmaceuticals USA logo

Osprey Pharmaceuticals USA

ospreypharma.com

Tactiva Therapeutics logo

Tactiva Therapeutics

NKT Therapeutics logo

NKT Therapeutics

Therapyx logo

Therapyx

therapyxinc.com

Tunitas Therapeutics - Quick Facts

Who are Tunitas Therapeutics' competitors?

Companies similar to Tunitas Therapeutics include Alladapt Immunotherapeutics, Tizona Therapeutics, Intrommune Therapeutics and Moonlight Therapeutics.

When was Tunitas Therapeutics founded?

Tunitas Therapeutics was founded in 2008.

Where is Tunitas Therapeutics' headquarters located?

Tunitas Therapeutics' headquarters is located in Los Altos, CA, US.

When was Tunitas Therapeutics' last funding round?

Tunitas Therapeutics' most recent funding round was for $10M (USD) in September 2015.

How much has Tunitas Therapeutics raised to-date?

As of Sep 30, 2015, Tunitas Therapeutics has raised a total of $10M (USD).

How many employees does Tunitas Therapeutics have?

Tunitas Therapeutics has 7 employees as of Feb 4, 2024.

Tunitas Therapeutics - Classification

Ownership
  • Private Equity
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Allergy Treatments
Tags
  • Biotech
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 12 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified